News

October 19, 2018October 19, 2018

FDA Approves New Label for Stiolto Respimat Showing Efficacy Against COPD Flare-ups

News

The U.S. Food and Drug Administration (FDA) approved a new label for Stiolto Respimat (a combination therapy of tiotropium bromide and olodaterol) based on data from clinical trials showing ... Read more

October 9, 2018October 9, 2018

VA Researchers Working on 3D-Printed Artificial Lung for Patients with COPD, Other Pulmonary Diseases

News

A fully functional 3D-printed artificial lung may someday help people with serious pulmonary illnesses, such as chronic obstructive pulmonary disease (COPD). A Department of Veterans Affairs (VA) research team, in ... Read more

October 2, 2018October 2, 2018

European Panel Recommends Broader Use of Trelegy Ellipta for COPD Patients

News

The triple therapy inhaler Trelegy Ellipta (fluticasone furoate, umeclidinium, vilanterol) has received a positive recommendation from the European Medicines Agency (EMA)‘s Committee for Medicinal Products for Human Use (CHMP) to expand its use to ... Read more

September 28, 2018September 28, 2018

Daliresp May Ease Lung Inflammation in COPD Patients by Effects on Immune Cells, Trial Data Suggests

News

The benefits of Daliresp (roflumilast), an approved chronic obstructive pulmonary disease therapy, may include an anti-inflammatory effect, with the treatment seen in a Phase 3 clinical trial to lower the number ... Read more

September 25, 2018September 25, 2018

Investigational PT010 Seen to Improve Lung Function of COPD Patients in Phase 3 Trial

News

AstraZeneca’s triple combination therapy PT010 (budesonide/glycopyrrolate/formoterol fumarate) improved lung function and reduced the rate of exacerbations in patients with moderate to very severe chronic obstructive pulmonary disease (COPD) in ... Read more

September 18, 2018September 18, 2018

Age, Mechanical Ventilation, Disease Severity Influence Hospital Mortality in COPD Patients, Study Says

News

A 10-year study has identified several factors that are independent predictors of hospital mortality in critically ill patients with severe chronic obstructive pulmonary disease (COPD). These factors include a patient’s ... Read more

September 11, 2018September 11, 2018

FDA Asks GSK for More Evidence of Mepolizumab’s Ability to Help Treat Flares in COPD Patients

News

GlaxoSmithKline’s application for approval of mepolizumab as an add-on therapy to reduce exacerbations in patients with chronic obstructive pulmonary disease (COPD) requires more clinical data, the U.S. Food and Drug Administration (FDA) said in ... Read more

September 7, 2018September 7, 2018

Two Phase 2 Trials Demonstrate RPL554 Has Potential to Enhance Bronchodilators’ Efficacy in COPD

News

The addition of Verona Pharma’s investigational agent RPL554 to standard short- and long-acting bronchodilators offers greater clinical benefits to patients with chronic obstructive pulmonary disease (COPD). Results of two ... Read more

September 4, 2018September 4, 2018

Testosterone Replacement Therapy Can Slow Men’s COPD, Study Finds

News

Testosterone replacement therapy can help slow the progression of chronic obstructive pulmonary disease (COPD) in men, a new study shows. Men with COPD tend to experience shortness of breath, ... Read more

August 31, 2018August 31, 2018

Switch to Electronic Cigarettes May Help COPD Patients, Study Reports

News

Electronic cigarettes help reduce exacerbations and improve exercise capacity in patients with chronic obstructive pulmonary disease (COPD) who saw their condition get worse by smoking conventional cigarettes, a new ... Read more

Pin It on Pinterest